Ceftriaxone + Azithromycin (Dual Therapy)
Treatment for Gonococcal infection
Typical Dosage: Ceftriaxone 500mg IM + Azithromycin 1g oral
Effectiveness
98%
Safety Score
70%
Clinical Trials
160
Participants
22K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Ceftriaxone 500mg IM + Azithromycin 1g oral
Time to Effect
1-3 days
Treatment Duration
Single dose
Evidence Quality
HIGHNumber Needed to Treat (NNT)
1.1(Treat 1.1 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
10(Treat 10 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$25
Monitoring:$150
Side Effect Mgmt:$20
Total Annual:$195
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0.07
Outcome-Based Costs
Cost per Responder
$199
Cost per Remission
$199
Ceftriaxone + Azithromycin (Dual Therapy) Outcomes
for Gonococcal infection
Efficacy Outcomes
Overall Effectiveness
+98%
Response Rate
+98%
Remission Rate
+98%
Common Side Effects
Injection site pain (Ceftriaxone)
+10%
Diarrhea (Azithromycin)
+14%
Nausea (Azithromycin)
+7%
Abdominal pain (Azithromycin)
+5%
Rash
+3%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov